Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Botta-Fridlund, D.
137  Ergebnisse:
Personensuche X
?
1

The presence of spontaneous portosystemic shunts increases ..:

Borentain, P. ; Soussan, J. ; Resseguier, N....
Diagnostic and Interventional Imaging.  97 (2016)  6 - p. 643-650 , 2016
Link: https://doi.org/10.1016/..
 
?
2

Sofosbuvir-Based-Regimen for HCV Recurrence after Combined ..:

Dharancy, S. ; Coilly, A. ; Fougerou-Leurent, C....
Journal of Hepatology.  64 (2016)  2 - p. S551 , 2016
Link: https://doi.org/10.1016/..
 
?
3

Should we keep using Ribavirin to Treat Hepatitis C Recurre..:

Houssel-Debry, P. ; Duvoux, C. ; Coilly, A....
Journal of Hepatology.  64 (2016)  2 - p. S144-S145 , 2016
Link: https://doi.org/10.1016/..
 
?
4

Renal Dysfunction in Liver Transplant Patients Treated with..:

Anty, R. ; Coilly, A. ; Fougerou, C....
Journal of Hepatology.  64 (2016)  2 - p. S550 , 2016
Link: https://doi.org/10.1016/..
 
?
5

P0137 : Safety of boceprevir-based triple therapy in HCV ci..:

Fontaine, H. ; Maynard-Muet, M. ; Bouix, C....
Journal of Hepatology.  62 (2015)  - p. S352-S353 , 2015
Link: https://doi.org/10.1016/..
 
?
6

P0804 : Efficacy of sofosbuvir-based treatment regimens in ..:

Antonini, T.M. ; Coilly, A. ; Radenne, S....
Journal of Hepatology.  62 (2015)  - p. S635-S636 , 2015
Link: https://doi.org/10.1016/..
 
?
7

G15 : The association of sofosbuvir and daclatasvir for tre..:

Coilly, A. ; Fougerou, C. ; De Ledinghen, V....
Journal of Hepatology.  62 (2015)  - p. S236-S237 , 2015
Link: https://doi.org/10.1016/..
 
?
8

O109 : Treatment of severe HCV-recurrence after liver trans..:

Dumortier, J. ; Botta-Fridlund, D. ; Coilly, A....
Journal of Hepatology.  62 (2015)  - p. S247-S248 , 2015
Link: https://doi.org/10.1016/..
 
?
9

LP05 : Daclatasvir plus sofosbuvir with or without ribaviri..:

Hezode, C. ; De Ledinghen, V. ; Fontaine, H....
Journal of Hepatology.  62 (2015)  - p. S265-S266 , 2015
Link: https://doi.org/10.1016/..
 
?
10

Aplasie médullaire chez un patient VHC greffé hépatique tra..:

Launay, M. ; Borentain, P. ; Kownacki, G....
Le Pharmacien Hospitalier et Clinicien.  49 (2014)  2 - p. e113-e114 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug moni..:

Chantry, AS ; Tching-Sin, M ; Dhiver, C...
BMC Infectious Diseases.  14 (2014)  S2 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
12

1422 END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI..:

Coilly, A. ; Dumortier, J. ; Botta-Fridlund, D....
Journal of Hepatology.  58 (2013)  - p. S572-S573 , 2013
Link: https://doi.org/10.1016/..
 
?
13

47 EFFICACY AND SAFETY OF PROTEASE INHIBITORS FOR SEVERE HE..:

Coilly, A. ; Roche, B. ; Botta-Fridlund, D....
Journal of Hepatology.  56 (2012)  - p. S21 , 2012
Link: https://doi.org/10.1016/..
 
?
14

520 INFRATHERAPEUTIC DOSES OF CALCINEURIN INHIBITORS ARE PO..:

Barbier, L.A. ; Garcia, S. ; Borentain, P....
Journal of Hepatology.  54 (2011)  - p. S213 , 2011
Link: https://doi.org/10.1016/..
 
?
15

115 PRE TRANSPLANT AFP LEVEL IS A SIMPLE AND USEFUL TEST FO..:

Duvoux, C. ; Decaens, T. ; Pessione, F....
Journal of Hepatology.  52 (2010)  - p. S51-S52 , 2010
Link: https://doi.org/10.1016/..
 
1-15